Coronavirus LIVE Updates: Johnson & Johnson began a 60,000-person trial of an experimental single-shot COVID-19 vaccine that, if proven effective, could simplify distribution of millions of doses compared with leading rivals requiring two doses.from Top India News- News18.com https://ift.tt/32Vpx56